The Current Status and Future Promise of SPR Biosensors

Nan-Fu Chiu

doi:10.3390/bios12110933

The Current Status and Future Promise of SPR Biosensors

Biosensors (Basel). 2022 Oct 27;12(11):933. doi: 10.3390/bios12110933.

Author

Nan-Fu Chiu^{1

2}

Affiliations

¹ Laboratory of Nano-Photonics and Biosensors, Institute and Undergraduate of Electro-Optical Engineering, National Taiwan Normal University, Taipei 11677, Taiwan.
² Department of Life Science, National Taiwan Normal University, Taipei 11677, Taiwan.

Abstract

The most commonly used protein detection methods in clinical diagnosis and disease monitoring are enzyme-linked immunosorbent assay (ELISA), Western blotting (immunoblot), and lateral flow assay (LFA) rapid screening, of which ELISA is the gold standard immunoassay in clinical practice [...].

Publication types

Editorial

MeSH terms

Biosensing Techniques* / methods
Enzyme-Linked Immunosorbent Assay / methods
Immunoassay / methods
Surface Plasmon Resonance*

Grants and funding

This research received no external funding.